Altimmune to report first quarter 2025 financial results and provide business update on may 13, 2025

Gaithersburg, md., may 06, 2025 (globe newswire) -- altimmune, inc. (nasdaq: alt), a late clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2025 financial results on tuesday, may 13, 2025.
ALT Ratings Summary
ALT Quant Ranking